Literature DB >> 22633564

OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.

Ji-Young Lee1, Kwan Soo Ko.   

Abstract

Among 213 Pseudomonas aeruginosa isolates collected from 10 South Korean hospitals, 57 isolates (26.8%) were carbapenem-resistant. All but three of the isolates had a relevant decrease of oprD expression. However, decreased oprD expression was also detected in five of ten carbapenem-susceptible isolates. Outer membrane protein analysis confirmed porin loss in carbapenem-resistant P. aeruginosa isolates. Based on the mutations of oprD gene sequences, carbapenem-resistant P. aeruginosa isolates could be classified into five oprD mutational groups. However, there was no difference of OprD expression or carbapenem minimum inhibitory concentrations among the five mutational groups. Among the 57 carbapenem-resistant P. aeruginosa isolates, 41 (71.9%) overexpressed efflux systems or ampC. MexAB-OprM and AmpC overexpression (56.1% and 47.4%, respectively) was prevalent and was significantly associated with carbapenem resistance. However, no synergistic effect of efflux systems and AmpC on carbapenem resistance was evident. In conclusion, combination of several mutation-driven mechanisms leading to OprD inactivation and overexpression of efflux systems was the main carbapenem resistance mechanism, but acquisition of a transferable resistance determinant such as metallo-β-lactamase could be problematic in clinical settings in South Korea.
Copyright © 2012 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22633564     DOI: 10.1016/j.ijantimicag.2012.04.004

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  34 in total

1.  A Pilot Study on Carbapenemase Detection: Do We See the Same Level of Agreement as with the CLSI Observations.

Authors:  Agila Kumari Pragasam; Rani Diana Sahni; Shalini Anandan; Archa Sharma; Radha Gopi; Noorjahan Hadibasha; Priya Gunasekaran; Balaji Veeraraghavan
Journal:  J Clin Diagn Res       Date:  2016-07-01

2.  Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.

Authors:  Yu Mi Wi; Kerryl E Greenwood-Quaintance; Audrey N Schuetz; Kwan Soo Ko; Kyong Ran Peck; Jae-Hoon Song; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

3.  Quinolone-resistant clinical strains of Pseudomonas aeruginosa isolated from University Hospital in Tunisia.

Authors:  Mouna Ben Nejma; Olfa Sioud; Maha Mastouri
Journal:  3 Biotech       Date:  2017-11-13       Impact factor: 2.406

4.  Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.

Authors:  Chi Hyun Kim; Hee Young Kang; Bo Ra Kim; Hyejin Jeon; Yoo Chul Lee; Sang Hwa Lee; Je Chul Lee
Journal:  J Microbiol       Date:  2016-01-05       Impact factor: 3.422

5.  Imipenem-Relebactam Susceptibility Testing of Gram-Negative Bacilli by Agar Dilution, Disk Diffusion, and Gradient Strip Methods Compared with Broth Microdilution.

Authors:  Hanna Hakvoort; Evelyn Bovenkamp; Kerryl E Greenwood-Quaintance; Suzannah M Schmidt-Malan; Jay N Mandrekar; Audrey N Schuetz; Robin Patel
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

6.  Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa.

Authors:  Yu Mi Wi; Ji-Young Choi; Ji-Young Lee; Cheol-In Kang; Doo Ryeon Chung; Kyong Ran Peck; Jae-Hoon Song; Kwan Soo Ko
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

7.  Persistence of Pseudomonas aeruginosa in a pulmonary nodule with late relapse.

Authors:  S Ronkainen; Y Xie; M Battiwalla; A J Barrett; F Stock; J P Dekker; R L Danner
Journal:  Transpl Infect Dis       Date:  2014-06-26       Impact factor: 2.228

8.  Similar frequencies of Pseudomonas aeruginosa isolates producing KPC and VIM carbapenemases in diverse genetic clones at tertiary-care hospitals in Medellín, Colombia.

Authors:  Johanna M Vanegas; Astrid V Cienfuegos; Ana M Ocampo; Lucelly López; Helena del Corral; Gustavo Roncancio; Patricia Sierra; Lina Echeverri-Toro; Sigifredo Ospina; Natalia Maldonado; Carlos Robledo; Andrea Restrepo; J Natalia Jiménez
Journal:  J Clin Microbiol       Date:  2014-09-10       Impact factor: 5.948

9.  Comparison of extended spectrum β-lactamases-producing Escherichia coli with non-ESBLs-producing E.coli: drug-resistance and virulence.

Authors:  Sha Li; Yan Qu; Dan Hu; Yong-Xin Shi
Journal:  World J Emerg Med       Date:  2012

10.  Emergence of VIM-2 and IMP-15 carbapenemases and inactivation of oprD gene in carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Lebanon.

Authors:  Charbel Al Bayssari; Seydina M Diene; Lotfi Loucif; Sushim Kumar Gupta; Fouad Dabboussi; Hassan Mallat; Monzer Hamze; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.